Zacks Research Has Optimistic Outlook of Integer Q2 Earnings

Integer Holdings Co. (NYSE:ITGR) – Analysts at Zacks Research lifted their Q2 2026 earnings per share (EPS) estimates for Integer in a research note issued to investors on Wednesday, May 28th. Zacks Research analyst R. Department now expects that the medical equipment provider will earn $1.69 per share for the quarter, up from their prior forecast of $1.62. The consensus estimate for Integer’s current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Integer’s Q3 2026 earnings at $1.72 EPS, Q4 2026 earnings at $1.89 EPS, FY2026 earnings at $6.90 EPS, Q1 2027 earnings at $1.74 EPS and FY2027 earnings at $7.44 EPS.

Other equities analysts have also recently issued research reports about the company. Benchmark cut their price target on Integer from $150.00 to $140.00 and set a “buy” rating for the company in a report on Friday, April 25th. Citigroup upgraded Integer from a “hold” rating to a “strong-buy” rating and raised their price target for the company from $133.00 to $140.00 in a report on Thursday, May 22nd. Raymond James raised their price objective on Integer from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, April 25th. Truist Financial set a $150.00 price objective on Integer and gave the company a “buy” rating in a research note on Friday, April 25th. Finally, KeyCorp lowered their price objective on Integer from $154.00 to $145.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $145.00.

Integer Stock Performance

NYSE ITGR opened at $119.48 on Friday. The stock has a market capitalization of $4.17 billion, a PE ratio of 35.56, a P/E/G ratio of 1.72 and a beta of 1.03. The business has a 50 day simple moving average of $118.60 and a two-hundred day simple moving average of $128.75. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. Integer has a 1-year low of $104.93 and a 1-year high of $146.36.

Integer (NYSE:ITGR) last released its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm had revenue of $437.39 million during the quarter, compared to analysts’ expectations of $428.51 million. During the same quarter last year, the business posted $1.14 earnings per share. The firm’s revenue was up 7.3% on a year-over-year basis.

Insider Activity at Integer

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the business’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer now owns 47,000 shares in the company, valued at $5,788,990. The trade was a 87.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.16% of the stock is owned by company insiders.

Institutional Investors Weigh In On Integer

Several hedge funds have recently made changes to their positions in ITGR. Mather Group LLC. lifted its holdings in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 143 shares during the period. Lee Danner & Bass Inc. purchased a new stake in shares of Integer in the 4th quarter worth $27,000. AdvisorNet Financial Inc purchased a new stake in shares of Integer in the 1st quarter worth $28,000. Opal Wealth Advisors LLC purchased a new stake in shares of Integer in the 1st quarter worth $28,000. Finally, Bessemer Group Inc. lifted its holdings in shares of Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider’s stock worth $35,000 after buying an additional 125 shares during the period. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.